Explore more by category
Period
Filter by
recent search
Showing: 1 – 5 of 154 stories
20 November 2023 – 1 mins read
Ipsen sponsors 5 elite athletes on their journeys to the 2024 Paralympics
Starting now and throughout 2024, Ipsen is sponsoring five talented, elite athletes on their journeys toward the 2024 Paralympic Games.
13 November 2023 – 1 mins read
The Liver Meeting 2023: Innovating for people living with rare liver diseases
Jennifer Schranz (Ipsen’s Global Head of Rare Diseases) attended The Liver Meeting from November 10-14, sharing key insights from her time onsite and explaining why scientific congresses are vital in helping advance innovation for patients.
10 November 2023 – 2 mins read
Ipsen’s mission to accelerate innovation in oncology
The outputs from the European Society of Medical Oncology (ESMO) Congress this year encompassed several important new data announcements, highlighting key advances in the development of therapies for people living with cancer. However, cancer remains a formidable global health challenge,…
10 November 2023 – 1 mins read
Examining the European Pharma legislation: EFPIA publishes the Dolon Report
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has commissioned Dolon to develop a report to assess the impact of the proposed European Commission pharma legislation. The Dolon Report, published on 6 November, has projected that the proposed legislation…
03 November 2023 – 0 mins read
Capital Markets Day 2023
Ipsen plans to host a capital-markets day, starting at 12.30 pm GMT on 7 December 2023, at The Brewery, London. In-person attendance is by invitation only.
